Clinical Trial Update: Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cryoablation combined with SHR-1701 and famitinib for advanced intrahepatic cholangiocarcinoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Famitinib (Famitinib)
• SHR-1701

Snippet

Sponsor: Fudan University | Conditions: Advanced Intrahepatic Cholangiocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING